United States - English - NLM (National Library of Medicine)

sanum kehlbeck gmbh & co. kg - penicillium roqueforti (unii: 7orp6r724l) (penicillium roqueforti - unii:7orp6r724l) - penicillium roqueforti 5 [hp_x] - for temporary relief of digestive symptoms such as fullness, pressure, or "gas" that occurs after eating.

United States - English - NLM (National Library of Medicine)

sanum kehlbeck gmbh & co. kg - penicillium roqueforti (unii: 7orp6r724l) (penicillium roqueforti - unii:7orp6r724l) - penicillium roqueforti 3 [hp_x] - for temporary relief of digestive symptoms such as fullness, pressure, or "gas" that occurs after eating.

United States - English - NLM (National Library of Medicine)

sanum kehlbeck gmbh & co. kg - penicillium roqueforti (unii: 7orp6r724l) (penicillium roqueforti - unii:7orp6r724l) - penicillium roqueforti 4 [hp_x] - for temporary relief of digestive symptoms such as fullness, pressure or "gas" that occur after eating.

United States - English - NLM (National Library of Medicine)

sanum kehlbeck gmbh & co. kg - penicillium glabrum (unii: 2in23yue0i) (penicillium glabrum - unii:2in23yue0i) - penicillium glabrum 4 [hp_x] - for temporary relief of congestion due to colds and minor respiratory infections.

United States - English - NLM (National Library of Medicine)

sanum kehlbeck gmbh & co. kg - penicillium glabrum (unii: 2in23yue0i) (penicillium glabrum - unii:2in23yue0i) - penicillium glabrum 3 [hp_x] - for temporary relief of congestion due to colds and minor respiratory infections.

United States - English - NLM (National Library of Medicine)

syntrion gmbh - penicillium glabrum (unii: 2in23yue0i) (penicillium glabrum - unii:2in23yue0i) - penicillium glabrum 4 [hp_x] - allergies for treatment of airborne allergies, contact allergies and neurodermatitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - penicillium notatum, quantity: 1 ml/ml (equivalent: penicillium notatum, qty 100 mg/ml) - extract, liquid - excipient ingredients: glycerol; sodium chloride; sodium bicarbonate; water for injections - indicated use of allergenic extracts is for the diagnosis and treatment (hypo-sensitization therapy) of patients who experience allergic symptoms.

United States - English - NLM (National Library of Medicine)

dna labs, inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), aspergillus niger var. niger (unii: 9ioa40ang6) (aspergillus niger var. niger - unii:9ioa40ang6), cochliobolus spicifer (unii: 91m9rwp3td) (cochliobolus spicifer - unii:91m9rwp3td), gibberella fujikuroi (unii: 815v716or2) (gibberella fujikuroi - unii:815v716or2), cochliobolus sativus (unii: 3ln5b70u4w) (cochliobolus sativus - unii:3ln5b70u4w), cladosporium bruhnei (unii: r1786y8h66) (cladosporium bruhnei - unii:r1786y8h6 - allergies.

United States - English - NLM (National Library of Medicine)

alk-abello, inc. - solidago canadensis pollen (unii: 644cz16ir5) (solidago canadensis pollen - unii:644cz16ir5) - equus caballus skin 20000 [pnu] in 1 ml - hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust, molds, animal danders, various other inhalants, and in situations where the offending allergen cannot be avoided. prior to initiation of therapy, the clinical sensitivity should be established by careful evaluation of the patient’s history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can easily be avoided. a patient should not be immunized with preparations of allergens to which the patient has not demonstrated symptoms, ige antibodies, positive skin tests, or properly controlled challenge testing. in most cases, immunotherapy is not indicated for those allergens that can be eliminated or minimized by environmental control. patients on beta-blockers are not candidates for immunotherapy, as they can be non-responsive to beta-agonists that may be required to reverse a systemic reaction (also see warnings and adverse

New Zealand - English - Medsafe (Medicines Safety Authority)

ebos group ltd - allergen extracts 100 pnu/ml (penicillium notatum, pyridine extract, alum precip. liq. ext); allergen extracts 1000 pnu/ml (penicillium notatum, pyridine extract, alum precip. liq. ext); allergen extracts 10000 pnu/ml (penicillium notatum, pyridine extract, alum precip. liq. ext) - suspension for injection - active: allergen extracts 100 pnu/ml (penicillium notatum, pyridine extract, alum precip. liq. ext) excipient: aluminium hydroxide phenol sodium chloride water for injection active: allergen extracts 1000 pnu/ml (penicillium notatum, pyridine extract, alum precip. liq. ext) excipient: aluminium hydroxide phenol sodium chloride water for injection active: allergen extracts 10000 pnu/ml (penicillium notatum, pyridine extract, alum precip. liq. ext) excipient: aluminium hydroxide phenol sodium chloride water for injection